Cannabis extract should be used to treat conditions that may benefit from an approach that includes cannabinoids other than CBD.

Prescriptions are issued exclusively by physicians on an individualized basis, as provided for by RDC No. 327/2019.

The Cannabis extract is made from a plant derivative that includes various substances from the plant, such as phytocannabinoids, terpenes, and flavonoids. On the other hand, Cannabidiol (CBD) is only one of the substances present in the Cannabis plant and is separated from other compounds through multiple purification and crystallization processes.

The term “full spectrum” is commonly used for imported products and can be translated as “full extract,” meaning that it contains all the substances found in the plant, as is the case with our product.
However, it is important to note that ANVISA does not recognize this terminology. According to RDC No. 1.015/2026, cannabis-based products are classified into only two categories: products containing up to 0.2% THC (tetrahydrocannabinol) and products containing more than 0.2% THC (tetrahydrocannabinol).

Ease Labs’ Cannabis sativa extract has the characteristic taste and aroma of natural cannabis oil, with no added artificial flavorings or flavoring agents. The product’s natural taste and aroma result from a complex combination of the terpenes and flavonoids present in the Cannabis plant.

Pharmacological safety, acute toxicity, and genotoxicity tests have been completed and confirm its safety. The test results are available in the Medical Area.

Any physician with an active registration with the CFM can prescribe cannabis products in Brazil using a white Special Control prescription form. The recommended use, dosage, and duration of treatment must be explained to the patient at the time of prescription.